WASHINGTON, Jan. 19 -- DLA TROOP SUPPORT, DEPT OF DEFENSE, has a requirement for "45--HEATER,WATER,ELECTR". The solicitation notice (SPE8E826T1601) was posted on Jan 19, 2026 01:22 am EST. All respons... Read More
WASHINGTON, Jan. 19 -- DLA LAND AND MARITIME, DEPT OF DEFENSE, has a requirement for "48--ACTUATOR,ELECTRO-ME". The solicitation notice (SPE7MC26T4374) was posted on Jan 19, 2026 01:22 am EST. All res... Read More
WASHINGTON, Jan. 19 -- DLA LAND AND MARITIME, DEPT OF DEFENSE, has a requirement for "25--ROLLER BEARING SUPP". The solicitation notice (SPE7LX26U3321) was posted on Jan 19, 2026 01:22 am EST. All res... Read More
WASHINGTON, Jan. 19 -- DLA LAND AND MARITIME, DEPT OF DEFENSE, has a requirement for "30--GEARSHAFT,SPUR". The solicitation notice (SPE7LX26U3316) was posted on Jan 19, 2026 01:22 am EST. All response... Read More
WASHINGTON, Jan. 19 -- DLA AVIATION, DEPT OF DEFENSE, has a requirement for "28--CONE,INNER PROPELLE". The solicitation notice (SPE4A626T514T) was posted on Jan 19, 2026 01:22 am EST. All responses ar... Read More
Washington, Jan. 19 -- Congressman Jason Crow issued the following press release: Congressman Jason Crow (D-CO-06) marked this year's Martin Luther King Jr. Day by participating in the Denver Marade,... Read More
WASHINGTON, Jan. 19 -- Sen. Jim Justice issued the following press release: Today, Senator Justice released a statement regarding an announcement from April of 2022 of a major investment with Frontie... Read More
WASHINGTON, Jan. 19 -- Sen. Martin Heinrich issued the following news release: U.S. Senator Martin Heinrich (D-N.M.) released the following statement in recognition of Martin Luther King, Jr. Day, wh... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07354919) titled 'Axelopran in Advanced Cancers' on Jan. 19. Study Type: Interventional Study ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355075) titled 'A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic De... Read More